Model to predict on-treatment restoration of functional HBV-specific CD8 + cell response foresees off-treatment HBV control in eAg-negative chronic hepatitis B.

Julia Peña-AsensioHenar CalvoJoaquín MiquelEduardo Sanz-de-VillalobosAlejandro González-PraetoriusMiguel TorralbaJuan-Ramón Larrubia

Published in: Alimentary pharmacology & therapeutics (2022)

cell response. Based on these predictors, a high likelihood of detecting this response at treatment withdrawal is associated with off-treatment HBV control and HBsAg decline and loss.

Keyphrases

hepatitis b virus
combination therapy
bone marrow
drug induced